New Delhi, Dec 1: The Delhi High Court on Thursday rejected the Central government’s notification seeking a ban on 344 fixed dose combination (FDC) medicines.
The brands included D’Cold Total, Corex cough syrup, and Vicks Action 500, among others.
Justice R.S. Endlaw quashed the Centre’s notification issued on March 10 and allowed the 454 pleas filed by the pharma companies
Companies like Pfizer, Glenmark, Procter and Gamble, Reckitt Benckiser, Cipla and others had knocked the court challenging the government decision. The court had taken hold on the notification.
The government had contended the court that FDC medicines sold by pharma majors “endanger patient safety”.
It had banned the drugs in the context that they involve risk to humans and hence needed to be withdrawn immediately and contended that the safer alternatives were available.
The pharma companies had debated that the ban order was passed without considering clinical data and had termed the government’s claim as absurd.